In Vivo Communications
In Vivo Communications is a privately held medical communications agency founded in 1996, operating across Australia and Asia-Pacific. It delivers strategic medical education, KOL advocacy, CME/CPD programmes, publications, and event management to pharmaceutical companies and medical organisations via Sydney and Singapore offices.
- Company typePrivate
- Founded1996
- HeadquartersSydney, Australia
- Headcount11–50
- GTM typeB2B
- OfferingServices
What In Vivo Communications does
In Vivo Communications is a privately held medical communications agency founded in Australia in 1996 and Singapore in 1999, providing strategic medical education, KOL advocacy, CME/CPD programmes, publications, event management and online education to pharmaceutical companies and medical organisations across the Asian and Australasian region. The company is headquartered in Sydney (Surry Hills, NSW) with a regional office in Singapore, operating through two legal entities — In Vivo Communications (Australia) Pty Limited and In Vivo Communications (Asia) Pte Limited.
The agency's core technology stack centres on two trademarked proprietary frameworks — KOL Researcher™, a KOL identification system combining quantitative market intelligence analysis with qualitative peer-interviewed research, and KOL Profiler™, an objective framework for assessing KOL decision influence and product support within a given therapy area. It also operates inVIVO Academy, an e-learning portal launched in 2010 for delivering accredited online CME/CPD courses, structured as a not-for-profit sister company and accredited by bodies including the Royal Australian College of General Practitioners (RACGP), ACRRM, APNA, ACP and PSA.
The business operates as a B2B professional-services agency with a direct client engagement model, delivering quote-based projects to enterprise pharmaceutical and medical-organisation clients. The company is independently owned and controlled by its founders/management, with no disclosed venture capital, private equity or institutional investor involvement. Revenue is not publicly disclosed, and there is no evidence of funding rounds, acquisitions, or recent leadership transitions in the available data.
In Vivo Communications firmographics
Firmographics- Name
- In Vivo Communications
- Legal name
- In Vivo Communications (Australia) Pty Limited and In Vivo Communications (Asia) Pte Limited
- Website
- https://invivocom.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- In Vivo Communications is a privately held medical communications agency founded in 1996, operating across Australia and Asia-Pacific. It delivers strategic medical education, KOL advocacy, CME/CPD programmes, publications, and event management to pharmaceutical companies and medical organisations via Sydney and Singapore offices.
- Ownership category
- akta.pro rank
In Vivo Communications industry classification
Industry- Product category
- Medical Communications and Strategic Medical Education
- NAICS
- Public Relations Agencies (541820), Other Services Related to Advertising (54189)
- akta.pro primary industry
- KOL Engagement & Medical Education (Advisory Boards/CME Support) (HLAGALAM)
- akta.pro secondary industries
- Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG), Medical Writing & Clinical Documentation FSP (HLAGAOAC)
Keywords
Where In Vivo Communications is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices2 records
Markets served
In Vivo Communications business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Medical Communications Services: In Vivo Communications generates revenue through providing medical communications services including medical writing, KOL advocacy programmes, CME/CPD programmes, event management, and online education. The company works directly with pharmaceutical companies and medical organizations on a project basis.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
In Vivo Communications product offering
Product offeringCore offering
In Vivo Communications is a medical communications agency that delivers strategic medical education services to pharmaceutical companies and medical organisations across Asia-Pacific. It combines medical writing, KOL advocacy programmes, CME/CPD programme delivery, event and conference management, and online education through its inVIVO Academy platform to develop and implement communications programmes spanning diverse audiences, cultures, and media channels.
Product overview
In Vivo Communications is a medical communications agency offering a suite of proprietary products and services for medical education. The core offerings include: inVIVO Academy, an e-learning portal for delivering accredited CME/CPD courses launched in 2010; KOL Researcher™ and KOL Profiler™, proprietary tools for key opinion leader identification and profiling; and service lines covering publications and strategic planning, event management, CME/CPD programmes, and online education. The company operates across Australia and Asia-Pacific, developing and implementing communication programmes for pharmaceutical companies and medical organisations.
Differentiator
Problem solved
Functional benefit
Brands
- inVIVO Academy: E-learning portal for delivering online and interactive CME and CPD courses, launched in 2010. Accredited by the Royal Australian College of General Practitioners as an independent provider of CPD for primary care physicians.
Products and services
- inVIVO Academy E-learning portal launched in 2010 for delivering online and interactive accredited CME and CPD courses to registered medical practitioners and allied health professionals across multiple therapy areas; functions as a not-for-profit sister company to In Vivo Communications.
- KOL Researcher™ Proprietary trademarked framework for identifying key opinion leaders, opinion leaders, and key prescribers using quantitative analysis of market intelligence sources and qualitative peer-interviewed research; supports advisory boards, speaking opportunities, and medical education activities.
- KOL Profiler™ Proprietary trademarked framework that objectively assesses a KOL's true decision influence and product support within a given therapy, enabling data aggregation and targeted KOL identification and relationship development.
- Publications and Strategic Planning Medical communications service covering manuscript development for peer-reviewed publications, abstract development and submission, clinical posters and oral presentations, sponsored journals, newsletters, review documents, and patient information programmes.
- Event Management End-to-end event management service for sponsored medical conferences, satellite symposia, exhibition stands, advisory board meetings, regional advocacy group meetings, and press events, covering concept development, venue coordination, budget management, faculty management, and meeting materials.
- CME/CPD Programmes Continuing medical education and continuing professional development programmes accredited by RACGP, ACRRM, APNA, ACP, and PSA, including clinical audits, active learning modules, case study programmes, and independent educational meetings.
- Online Education Online education delivery service enabling sponsored CME/CPD modules that meet target audience educational interests and accreditation requirements via the inVIVO Academy platform.
Companies that use In Vivo Communications
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
In Vivo Communications technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
In Vivo Communications partnerships and signals
Strategic signalScale indicators1 record
Recent moves3 records
Expansion highlights3 records
In Vivo Communications competitors and assessment
Company assessmentBroad incumbents
- Publicis Health: Publicis Groupe's health communications network offering medical education, KOL strategy, and publications. Direct overlap on In Vivo's core services (CME, KOL, publications), with multinational scale and broader therapeutic-area depth.
- Ogilvy Health: WPP's global health communications arm providing medical education, publications, and KOL services. Comparable in service mix (medical writing, CME/CPD, KOL programmes) but with global network reach that In Vivo's boutique APAC footprint cannot match.
- Syneos Health Communications: Integrated clinical-to-commercial biopharma services organization with a dedicated medical communications practice. Comparable in KOL engagement, medical writing, and CME/CPD, with significantly larger global reach and combined clinical/commercial offerings.
- Havas Health & You: Havas' global health and wellness network providing medical communications, KOL engagement, and content strategy. Overlaps with In Vivo on medical writing, CME/CPD, and advisory board services, but with broader portfolio and full-service agency capabilities.
- McCann Health: Global health communications network within IPG offering medical communications, KOL engagement, and CME across APAC. Directly comparable to In Vivo's medical communications offering, but operates at much larger scale and as part of a broader agency holding company.
Direct peers
- MedThink Communications: Specialist medical communications agency providing medical writing, KOL engagement, and CME services to pharma clients. Direct peer in service mix and boutique medcomms model, primarily serving North American and global pharma.
- Complete HealthVizion: Specialist medical communications and medical education agency offering publications planning, KOL engagement, and CME/CPD programmes. Comparable boutique medcomms model targeting the same pharma-sponsored medical education market as In Vivo.
- Caudex: Specialist medical communications agency (part of IPG Health) providing medical writing, publications, and KOL programmes. Direct competitor to In Vivo in the medcomms space, with comparable service model but stronger backing from a global holding company.
- Ashfield Health (Inizio): Specialist medical communications and healthcare agency group within Inizio providing KOL engagement, medical writing, and CME services. Closely comparable service mix to In Vivo Communications, often competing for the same pharma-sponsored medcomms work.
- Nucleus Global: Medical communications agency group offering KOL engagement, medical education, and scientific content services. Highly comparable to In Vivo's specialist medcomms positioning, with offices across multiple regions including APAC.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
In Vivo Communications social profiles
Digital presenceIn Vivo Communications financial estimates
Financial estimateRevenue estimate
Valuation estimate
In Vivo Communications leadership team
Management profileNumber of profiles
Profiles1 record
In Vivo Communications subsidiaries and ownership
Company hierarchySubsidiaries1 record
In Vivo Communications funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
In Vivo Communications M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about In Vivo Communications
What does In Vivo Communications do?
In Vivo Communications is a medical communications agency that delivers strategic medical education services to pharmaceutical companies and medical organisations across Asia-Pacific. It combines medical writing, KOL advocacy programmes, CME/CPD programme delivery, event and conference management, and online education through its inVIVO Academy platform to develop and implement communications programmes spanning diverse audiences, cultures, and media channels.
Is In Vivo Communications a public or private company?
In Vivo Communications is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was In Vivo Communications founded?
In Vivo Communications was founded in 1996. It employs 11 to 50 people.
Where is In Vivo Communications based?
In Vivo Communications is headquartered in Sydney, Australia, in the Oceania region.
How does In Vivo Communications make money?
One revenue line is on record: medical Communications Services.
Who are In Vivo Communications's main competitors?
Broad incumbents on record are Publicis Health, Ogilvy Health, Syneos Health Communications, Havas Health & You and McCann Health. Direct peers are MedThink Communications, Complete HealthVizion, Caudex, Ashfield Health (Inizio) and Nucleus Global.
Does In Vivo Communications have an API?
No public API is recorded for In Vivo Communications.
What industry is In Vivo Communications in?
In Vivo Communications's product category is Medical Communications and Strategic Medical Education. Its primary akta.pro industry code is HLAGALAM, KOL Engagement & Medical Education (Advisory Boards/CME Support), with a secondary code of HLAGAOAG, Medical Affairs, Scientific Communications & HEOR FSP. Its NAICS code is 541820.